Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Gynecology

  Free Subscription


Articles published in Clin Cancer Res

Retrieve available abstracts of 98 articles:
HTML format

Single Articles


    June 2008
  1. SOEGAARD M , Kjaer SK, Cox M, Wozniak E, et al
    BRCA1 and BRCA2 Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark.
    Clin Cancer Res. 2008;14:3761-7.
    PubMed     Related articles    Abstract available


  2. BANZATO A , Bobisse S, Rondina M, Renier D, et al
    A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic Activity.
    Clin Cancer Res. 2008;14:3598-606.
    PubMed     Related articles    Abstract available


  3. TSURUTA Y , Pereboeva L, Breidenbach M, Rein DT, et al
    A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.
    Clin Cancer Res. 2008;14:3582-8.
    PubMed     Related articles    Abstract available


  4. HAN LY , Fletcher MS, Urbauer DL, Mueller P, et al
    HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma.
    Clin Cancer Res. 2008;14:3372-9.
    PubMed     Related articles    Abstract available


  5. SUEHIRO Y , Okada T, Okada T, Anno K, et al
    Aneuploidy Predicts Outcome in Patients with Endometrial Carcinoma and Is Related to Lack of CDH13 Hypermethylation.
    Clin Cancer Res. 2008;14:3354-61.
    PubMed     Related articles    Abstract available


  6. WOLOSZYNSKA-READ A , Mhawech-Fauceglia P, Yu J, Odunsi K, et al
    Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer.
    Clin Cancer Res. 2008;14:3283-90.
    PubMed     Related articles    Abstract available


  7. STEFFENSEN KD , Waldstrom M, Olsen DA, Corydon T, et al
    Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.
    Clin Cancer Res. 2008;14:3278-82.
    PubMed     Related articles    Abstract available


    May 2008
  8. DEVALAPALLY H , Duan Z, Seiden MV, Amiji MM, et al
    Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.
    Clin Cancer Res. 2008;14:3193-203.
    PubMed     Related articles    Abstract available


  9. ISHIBASHI M , Nakayama K, Yeasmin S, Katagiri A, et al
    A BTB/POZ Gene, NAC-1, a Tumor Recurrence-Associated Gene, as a Potential Target for Taxol Resistance in Ovarian Cancer.
    Clin Cancer Res. 2008;14:3149-55.
    PubMed     Related articles    Abstract available


  10. RADER JS , Aylsworth CF, Juckett DA, Mutch DG, et al
    Phase I Study and Preliminary Pharmacology of the Novel Innate Immune Modulator rBBX-01 in Gynecologic Cancers.
    Clin Cancer Res. 2008;14:3089-97.
    PubMed     Related articles    Abstract available


  11. DUNCAN TJ , Al-Attar A, Rolland P, Scott IV, et al
    Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
    Clin Cancer Res. 2008;14:3030-5.
    PubMed     Related articles    Abstract available


  12. WITTNER BS , Sgroi DC, Ryan PD, Bruinsma TJ, et al
    Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort.
    Clin Cancer Res. 2008;14:2988-2993.
    PubMed     Related articles    Abstract available


  13. MILNE RL , Osorio A, Cajal TR, Vega A, et al
    The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in Spain.
    Clin Cancer Res. 2008;14:2861-9.
    PubMed     Related articles    Abstract available


  14. DIEFENBACH CS , Gnjatic S, Sabbatini P, Aghajanian C, et al
    Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission.
    Clin Cancer Res. 2008;14:2740-2748.
    PubMed     Related articles    Abstract available


  15. NAM EJ , Yoon H, Kim SW, Kim H, et al
    MicroRNA Expression Profiles in Serous Ovarian Carcinoma.
    Clin Cancer Res. 2008;14:2690-5.
    PubMed     Related articles    Abstract available


  16. LU KH , Wu W, Dave B, Slomovitz BM, et al
    Loss of tuberous sclerosis complex-2 function and activation of Mammalian target of rapamycin signaling in endometrial carcinoma.
    Clin Cancer Res. 2008;14:2543-50.
    PubMed     Related articles    Abstract available


  17. LEE JW , Choi CH, Choi JJ, Park YA, et al
    Altered MicroRNA Expression in Cervical Carcinomas.
    Clin Cancer Res. 2008;14:2535-42.
    PubMed     Related articles    Abstract available


    April 2008
  18. EGORIN MJ
    Population pharmacokinetc/pharmacodynamic modeling of Paclitaxel and Carboplatin in ovarian cancer.
    Clin Cancer Res. 2008;14:2517.
    PubMed     Related articles   


  19. KATO T , Sato N, Takano A, Miyamoto M, et al
    Activation of Placenta-Specific Transcription Factor Distal-less Homeobox 5 Predicts Clinical Outcome in Primary Lung Cancer Patients.
    Clin Cancer Res. 2008;14:2363-70.
    PubMed     Related articles    Abstract available


  20. INO K , Yamamoto E, Shibata K, Kajiyama H, et al
    Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival.
    Clin Cancer Res. 2008;14:2310-2317.
    PubMed     Related articles    Abstract available


  21. NELSON EL , Wenzel LB, Osann K, Dogan-Ates A, et al
    Stress, Immunity, and Cervical Cancer: Biobehavioral Outcomes of a Randomized Clinical Trail.
    Clin Cancer Res. 2008;14:2111-2118.
    PubMed     Related articles    Abstract available


  22. JORDANOVA ES , Gorter A, Ayachi O, Prins F, et al
    Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?
    Clin Cancer Res. 2008;14:2028-2035.
    PubMed     Related articles    Abstract available


    March 2008
  23. JIA L , Liu Y, Yi X, Miron A, et al
    Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous Carcinoma.
    Clin Cancer Res. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text


  24. MEZZANZANICA D , Fabbi M, Bagnoli M, Staurengo S, et al
    Subcellular Localization of Activated Leukocyte Cell Adhesion Molecule Is a Molecular Predictor of Survival in Ovarian Carcinoma Patients.
    Clin Cancer Res. 2008;14:1726-1733.
    PubMed     Related articles    Abstract available


  25. YEASMIN S , Nakayama K, Ishibashi M, Katagiri A, et al
    Expression of the Bric-a-Brac Tramtrack Broad Complex Protein NAC-1 in Cervical Carcinomas Seems to Correlate with Poorer Prognosis.
    Clin Cancer Res. 2008;14:1686-91.
    PubMed     Related articles    Abstract available


    February 2008
  26. WALSH MD , Cummings MC, Buchanan DD, Dambacher WM, et al
    Molecular, Pathologic, and Clinical Features of Early-Onset Endometrial Cancer: Identifying Presumptive Lynch Syndrome Patients.
    Clin Cancer Res. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text


  27. SONG H , Hogdall E, Ramus SJ, Dicioccio RA, et al
    Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
    Clin Cancer Res. 2008;14:1090-5.
    PubMed     Related articles    Abstract available


  28. VISINTIN I , Feng Z, Longton G, Ward DC, et al
    Diagnostic Markers for Early Detection of Ovarian Cancer.
    Clin Cancer Res. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text


  29. GAGNON A , Kim JH, Schorge JO, Ye B, et al
    Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients.
    Clin Cancer Res. 2008;14:764-771.
    PubMed     Related articles    Abstract available


  30. HEFLER LA , Concin N, Hofstetter G, Marth C, et al
    Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer.
    Clin Cancer Res. 2008;14:710-4.
    PubMed     Related articles    Abstract available


    January 2008
  31. JU XZ , Yang JM, Zhou XY, Li ZT, et al
    EMMPRIN Expression as a Prognostic Factor in Radiotherapy of Cervical Cancer.
    Clin Cancer Res. 2008;14:494-501.
    PubMed     Related articles    Abstract available


  32. WELTERS MJ , Kenter GG, Piersma SJ, Vloon AP, et al
    Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine.
    Clin Cancer Res. 2008;14:178-87.
    PubMed     Related articles    Abstract available


  33. KENTER GG , Welters MJ, Valentijn AR, Lowik MJ, et al
    Phase I immunotherapeutic trial with long peptides spanning the e6 and e7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Clin Cancer Res. 2008;14:169-77.
    PubMed     Related articles    Abstract available


  34. BARTEL F , Jung J, Bohnke A, Gradhand E, et al
    Both Germ Line and Somatic Genetics of the p53 Pathway Affect Ovarian Cancer Incidence and Survival.
    Clin Cancer Res. 2008;14:89-96.
    PubMed     Related articles    Abstract available


  35. YAMAGUCHI K , Mandai M, Toyokuni S, Hamanishi J, et al
    Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress.
    Clin Cancer Res. 2008;14:32-40.
    PubMed     Related articles    Abstract available


    December 2007
  36. KAMAT AA , Merritt WM, Coffey D, Lin YG, et al
    Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
    Clin Cancer Res. 2007;13:7487-95.
    PubMed     Related articles    Abstract available


  37. QUINN JE , James CR, Stewart GE, Mulligan JM, et al
    BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after Chemotherapy.
    Clin Cancer Res. 2007;13:7413-20.
    PubMed     Related articles    Abstract available


  38. JACKSON D , Craven RA, Hutson RC, Graze I, et al
    Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
    Clin Cancer Res. 2007;13:7370-9.
    PubMed     Related articles    Abstract available


  39. CANNISTRA SA
    BRCA-1 in Sporadic Epithelial Ovarian Cancer: Lessons Learned from the Genetics of Hereditary Disease.
    Clin Cancer Res. 2007;13:7225-7.
    PubMed     Related articles   


  40. WITHAM J , Valenti MR, De-Haven-Brandon AK, Vidot S, et al
    The Bcl-2/Bcl-XL Family Inhibitor ABT-737 Sensitizes Ovarian Cancer Cells to Carboplatin.
    Clin Cancer Res. 2007;13:7191-8.
    PubMed     Related articles    Abstract available


  41. YANG T , Wall EM, Milne K, Theiss P, et al
    CD8+ T Cells Induce Complete Regression of Advanced Ovarian Cancers by an Interleukin (IL)-2/IL-15 Dependent Mechanism.
    Clin Cancer Res. 2007;13:7172-80.
    PubMed     Related articles    Abstract available


  42. THAM LS , Holford NH, Hor SY, Tan T, et al
    Lack of Association of Single-Nucleotide Polymorphisms in Pregnane X Receptor, Hepatic Nuclear Factor 4{alpha}, and Constitutive Androstane Receptor with Docetaxel Pharmacokinetics.
    Clin Cancer Res. 2007;13:7126-32.
    PubMed     Related articles    Abstract available


  43. ZHENG Y , Katsaros D, Shan SJ, de la Longrais IR, et al
    A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy.
    Clin Cancer Res. 2007;13:6984-92.
    PubMed     Related articles    Abstract available


  44. RESSLER S , Scheiden R, Dreier K, Laich A, et al
    High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
    Clin Cancer Res. 2007;13:7067-72.
    PubMed     Related articles    Abstract available


    November 2007
  45. ANNUNZIATA CM , Kleinberg L, Davidson B, Berner A, et al
    BAG-4/SODD and Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer.
    Clin Cancer Res. 2007;13:6585-6592.
    PubMed     Related articles    Abstract available


  46. SONG J , Shih IM, Salani R, Chan DW, et al
    Annexin XI Is Associated with Cisplatin Resistance and Related to Tumor Recurrence in Ovarian Cancer Patients.
    Clin Cancer Res. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text


  47. JOERGER M , Huitema AD, Richel DJ, Dittrich C, et al
    Population Pharmacokinetics and Pharmacodynamics of Paclitaxel and Carboplatin in Ovarian Cancer Patients: A Study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Grou
    Clin Cancer Res. 2007;13:6410-6418.
    PubMed     Related articles    Abstract available


  48. HAMA Y , Urano Y, Koyama Y, Gunn AJ, et al
    A Self-Quenched Galactosamine-Serum Albumin-RhodamineX Conjugate: A "Smart" Fluorescent Molecular Imaging Probe Synthesized with Clinically Applicable Material for Detecting Peritoneal Ovarian Cancer Metastases.
    Clin Cancer Res. 2007;13:6335-6343.
    PubMed     Related articles    Abstract available


    October 2007
  49. KULKARNI AA , Loddo M, Leo E, Rashid M, et al
    DNA Replication Licensing Factors and Aurora Kinases are Linked to Aneuploidy and Clinical Outcome in Epithelial Ovarian Carcinoma.
    Clin Cancer Res. 2007;13:6153-6161.
    PubMed     Related articles    Abstract available


  50. O'CONNOR JP , Jayson GC, Jackson A, Ghiorghiu D, et al
    Enhancing Fraction Predicts Clinical Outcome following First-Line Chemotherapy in Patients with Epithelial Ovarian Carcinoma.
    Clin Cancer Res. 2007;13:6130-5.
    PubMed     Related articles    Abstract available


  51. SHARMA S , Tammela J, Wang X, Arnouk H, et al
    Characterization of a Putative Ovarian Oncogene, Elongation Factor 1{alpha}, Isolated by Panning a Synthetic Phage Display Single-Chain Variable Fragment Library with Cultured Human Ovarian Cancer Cells.
    Clin Cancer Res. 2007;13:5889-96.
    PubMed     Related articles    Abstract available


  52. GUAN Y , Kuo WL, Stilwell JL, Takano H, et al
    Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer.
    Clin Cancer Res. 2007;13:5745-55.
    PubMed     Related articles    Abstract available


  53. FREEDMAN RS , Wang E, Voiculescu S, Patenia R, et al
    Comparative Analysis of Peritoneum and Tumor Eicosanoids and Pathways in Advanced Ovarian Cancer.
    Clin Cancer Res. 2007;13:5736-5744.
    PubMed     Related articles    Abstract available


    September 2007
  54. MEREDITH RF , Buchsbaum DJ, Alvarez RD, Lobuglio AF, et al
    Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.
    Clin Cancer Res. 2007;13:5643s-5s.
    PubMed     Related articles    Abstract available


  55. ZHANG L , Huang J, Yang N, Greshock J, et al
    Integrative Genomic Analysis of Phosphatidylinositol 3'-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer.
    Clin Cancer Res. 2007;13:5314-21.
    PubMed     Related articles    Abstract available


  56. HASSAN R , Bullock S, Premkumar A, Kreitman RJ, et al
    Phase I Study of SS1P, a Recombinant Anti-Mesothelin Immunotoxin Given as a Bolus I.V. Infusion to Patients with Mesothelin-Expressing Mesothelioma, Ovarian, and Pancreatic Cancers.
    Clin Cancer Res. 2007;13:5144-9.
    PubMed     Related articles    Abstract available


    August 2007
  57. GORRINGE KL , Jacobs S, Thompson ER, Sridhar A, et al
    High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.
    Clin Cancer Res. 2007;13:4731-9.
    PubMed     Related articles    Abstract available


  58. BEDROSIAN I , Lee C, Tucker SL, Palla SL, et al
    Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy.
    Clin Cancer Res. 2007;13:4800-6.
    PubMed     Related articles    Abstract available


  59. VAN HOLSBEKE C , Van Calster B, Valentin L, Testa AC, et al
    External validation of mathematical models to distinguish between benign and malignant adnexal tumors: a multicenter study by the international ovarian tumor analysis group.
    Clin Cancer Res. 2007;13:4440-7.
    PubMed     Related articles    Abstract available


  60. MCINTOSH MW , Liu Y, Drescher C, Urban N, et al
    Validation and Characterization of Human Kallikrein 11 as a Serum Marker for Diagnosis of Ovarian Carcinoma.
    Clin Cancer Res. 2007;13:4422-4428.
    PubMed     Related articles    Abstract available


    July 2007
  61. MABUCHI S , Altomare DA, Cheung M, Zhang L, et al
    RAD001 Inhibits Human Ovarian Cancer Cell Proliferation, Enhances Cisplatin-Induced Apoptosis, and Prolongs Survival in an Ovarian Cancer Model.
    Clin Cancer Res. 2007;13:4261-70.
    PubMed     Related articles    Abstract available


  62. LU C , Kamat AA, Lin YG, Merritt WM, et al
    Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma.
    Clin Cancer Res. 2007;13:4209-17.
    PubMed     Related articles    Abstract available


  63. KUBISTA E , Planellas Gomez JV, Dowsett M, Foidart JM, et al
    Effect of Tibolone on Breast Cancer Cell Proliferation in Postmenopausal ER+ Patients: Results from STEM Trial.
    Clin Cancer Res. 2007;13:4185-90.
    PubMed     Related articles    Abstract available


  64. SABBATINI PJ , Ragupathi G, Hood C, Aghajanian CA, et al
    Pilot Study of a Heptavalent Vaccine-Keyhole Limpet Hemocyanin Conjugate plus QS21 in Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer.
    Clin Cancer Res. 2007;13:4170-7.
    PubMed     Related articles    Abstract available


  65. DUNCAN TJ , Rolland P, Deen S, Scott IV, et al
    Loss of IFN{gamma} Receptor Is an Independent Prognostic Factor in Ovarian Cancer.
    Clin Cancer Res. 2007;13:4139-45.
    PubMed     Related articles    Abstract available


  66. LANDEN CN JR , Lin YG, Immaneni A, Deavers MT, et al
    Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients.
    Clin Cancer Res. 2007;13:4098-104.
    PubMed     Related articles    Abstract available


  67. LASSMANN S , Shen Y, Jutting U, Wiehle P, et al
    Predictive Value of Aurora-A/STK15 Expression for Late Stage Epithelial Ovarian Cancer Patients Treated by Adjuvant Chemotherapy.
    Clin Cancer Res. 2007;13:4083-91.
    PubMed     Related articles    Abstract available


  68. SMITH KL , Adank M, Kauff N, Lafaro K, et al
    BRCA mutations in women with ductal carcinoma in situ.
    Clin Cancer Res. 2007;13:4306-10.
    PubMed     Related articles    Abstract available


  69. FORSTER M , Kaye S, Oza A, Sklenar I, et al
    A phase Ib and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer.
    Clin Cancer Res. 2007;13:4178-84.
    PubMed     Related articles    Abstract available


  70. SCHULTES BC , Smith LM, Nicodemus CF
    Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
    Clin Cancer Res. 2007;13:4026.
    PubMed     Related articles   


  71. BURGES A , Wimberger P, Kumper C, Gorbounova V, et al
    Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM x Anti-CD3 Antibody: A Phase I/II Study.
    Clin Cancer Res. 2007;13:3899-3905.
    PubMed     Related articles    Abstract available


  72. YOUNG TW , Rosen DG, Mei FC, Li N, et al
    Up-regulation of Tumor Susceptibility Gene 101 Conveys Poor Prognosis through Suppression of p21 Expression in Ovarian Cancer.
    Clin Cancer Res. 2007;13:3848-54.
    PubMed     Related articles    Abstract available


    June 2007
  73. SMYTH JF , Gourley C, Walker G, Mackean MJ, et al
    Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients.
    Clin Cancer Res. 2007;13:3617-22.
    PubMed     Related articles    Abstract available


  74. ROLLAND P , Deen S, Scott I, Durrant L, et al
    Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
    Clin Cancer Res. 2007;13:3591-6.
    PubMed     Related articles    Abstract available


  75. LIN YG , Kunnumakkara AB, Nair A, Merritt WM, et al
    Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-{kappa}B Pathway.
    Clin Cancer Res. 2007;13:3423-30.
    PubMed     Related articles    Abstract available


  76. GOYENECHE AA , Caron RW, Telleria CM
    Mifepristone Inhibits Ovarian Cancer Cell Growth In vitro and In vivo.
    Clin Cancer Res. 2007;13:3370-9.
    PubMed     Related articles    Abstract available


  77. SANTIN AD , Bellone S, Siegel ER, McKenney JK, et al
    Overexpression of Clostridium perfringens Enterotoxin Receptors Claudin-3 and Claudin-4 in Uterine Carcinosarcomas.
    Clin Cancer Res. 2007;13:3339-3346.
    PubMed     Related articles    Abstract available


    May 2007
  78. ZIGHELBOIM I , Goodfellow PJ, Schmidt AP, Walls KC, et al
    Differential Methylation Hybridization Array of Endometrial Cancers Reveals Two Novel Cancer-Specific Methylation Markers.
    Clin Cancer Res. 2007;13:2882-2889.
    PubMed     Related articles    Abstract available


  79. LAPING NJ , Everitt JI, Frazier KS, Burgert M, et al
    Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats.
    Clin Cancer Res. 2007;13:3087-99.
    PubMed     Related articles    Abstract available


  80. TSURUTA Y , Pereboeva L, Glasgow JN, Rein DT, et al
    A Mosaic Fiber Adenovirus Serotype 5 Vector Containing Reovirus {sigma}1 and Adenovirus Serotype 3 Knob Fibers Increases Transduction in an Ovarian Cancer Ex vivo System via a Coxsackie and Adenovirus Receptor-Independent Pathway.
    Clin Cancer Res. 2007;13:2777-2783.
    PubMed     Related articles    Abstract available


  81. CASTLE PE , Dockter J, Giachetti C, Garcia FA, et al
    A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.
    Clin Cancer Res. 2007;13:2599-605.
    PubMed     Related articles    Abstract available


  82. TANG X , Zhang Q, Nishitani J, Brown J, et al
    Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells.
    Clin Cancer Res. 2007;13:2568-76.
    PubMed     Related articles    Abstract available


    April 2007
  83. LAMBECK AJ , Crijns AP, Leffers N, Sluiter WJ, et al
    Serum Cytokine Profiling as a Diagnostic and Prognostic Tool in Ovarian Cancer: A Potential Role for Interleukin 7.
    Clin Cancer Res. 2007;13:2385-2391.
    PubMed     Related articles    Abstract available


  84. BARDELLA C , Dettori D, Olivero M, Coltella N, et al
    The Therapeutic Potential of Hepatocyte Growth Factor to Sensitize Ovarian Cancer Cells to Cisplatin and Paclitaxel In vivo.
    Clin Cancer Res. 2007;13:2191-8.
    PubMed     Related articles    Abstract available


    March 2007
  85. DANG Y , Knutson KL, Goodell V, dela Rosa C, et al
    Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
    Clin Cancer Res. 2007;13:1883-91.
    PubMed     Related articles    Abstract available


  86. WIEDENMANN N , Valdecanas D, Hunter N, Hyde S, et al
    130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
    Clin Cancer Res. 2007;13:1868-74.
    PubMed     Related articles    Abstract available


  87. DORN J , Schmitt M, Kates R, Schmalfeldt B, et al
    Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.
    Clin Cancer Res. 2007;13:1742-8.
    PubMed     Related articles    Abstract available


  88. RISINGER JI , Chandramouli GV, Maxwell GL, Custer M, et al
    Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression.
    Clin Cancer Res. 2007;13:1713-9.
    PubMed     Related articles    Abstract available


  89. JAMIESON D , Wilson K, Pridgeon S, Margetts JP, et al
    NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Activity and Expression in Bladder and Ovarian Cancer and Lower NRH:Quinone Oxidoreductase 2 Activity Associated with an NQO2 Exon 3 Single-Nucleotide Polymorphism.
    Clin Cancer Res. 2007;13:1584-90.
    PubMed     Related articles    Abstract available


  90. WALKER G , Macleod K, Williams AR, Cameron DA, et al
    Insulin-like Growth Factor Binding Proteins IGFBP3, IGFBP4, and IGFBP5 Predict Endocrine Responsiveness in Patients with Ovarian Cancer.
    Clin Cancer Res. 2007;13:1438-44.
    PubMed     Related articles    Abstract available


  91. GARG M , Chaurasiya D, Rana R, Jagadish N, et al
    Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Clin Cancer Res. 2007;13:1421-8.
    PubMed     Related articles    Abstract available


  92. FENG YZ , Shiozawa T, Miyamoto T, Kashima H, et al
    Overexpression of hedgehog signaling molecules and its involvement in the proliferation of endometrial carcinoma cells.
    Clin Cancer Res. 2007;13:1389-98.
    PubMed     Related articles    Abstract available


    February 2007
  93. ZENG X , Yan T, Schupp JE, Seo Y, et al
    DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
    Clin Cancer Res. 2007;13:1315-21.
    PubMed     Related articles    Abstract available


  94. LEO C , Horn LC, Rauscher C, Hentschel B, et al
    Lack of apoptotic protease activating factor-1 expression and resistance to hypoxia-induced apoptosis in cervical cancer.
    Clin Cancer Res. 2007;13:1149-53.
    PubMed     Related articles    Abstract available


  95. HEFLER LA , Mustea A, Konsgen D, Concin N, et al
    Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.
    Clin Cancer Res. 2007;13:898-901.
    PubMed     Related articles    Abstract available


    September 2006
  96. OGURA T , Kobayashi H, Ueoka Y, Okugawa K, et al
    Adenovirus-Mediated Calponin h1 Gene Therapy Directed against Peritoneal Dissemination of Ovarian Cancer: Bifunctional Therapeutic Effects on Peritoneal Cell Layer and Cancer Cells.
    Clin Cancer Res. 2006;12:5216-23.
    PubMed     Related articles    Abstract available   Free Full Text


  97. DUAN Z , Foster R, Bell DA, Mahoney J, et al
    Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
    Clin Cancer Res. 2006;12:5055-63.
    PubMed     Related articles    Abstract available   Free Full Text


    July 2006
  98. MARSH S , King CR, McLeod HL, Paul J, et al
    ABCB1 2677G>T/A Genotype and Paclitaxel Pharmacogenetics in Ovarian Cancer.
    Clin Cancer Res. 2006;12:4127-9.
    PubMed     Related articles       Free Full Text


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: